位元堂二零二五年年报

According to authoritative market research reports,Wai Yuen Tong is widely recognized as the leading brand offeringthe best quality Chinese medicine among various brands in the sector. Contents目錄 CORPORATE INFORMATION2AWARDS5CHAIRMAN’S STATEMENT6MANAGEMENT DISCUSSION AND ANALYSIS10BOARD OF DIRECTORS AND SENIOR MANAGEMENT21CORPORATE GOVERNANCE REPORT28REPORT OF THE DIRECTORS56INDEPENDENT AUDITOR’S REPORT72CONSOLIDATED STATEMENT OF PROFIT OR LOSS ANDOTHER COMPREHENSIVE INCOME78CONSOLIDATED STATEMENT OF FINANCIAL POSITION81CONSOLIDATED STATEMENT OF CHANGES IN EQUITY83CONSOLIDATED STATEMENT OF CASH FLOWS85NOTES TO FINANCIAL STATEMENTS88FIVE YEAR FINANCIAL SUMMARY247 Corporate Information公司資料 BOARD OF DIRECTORS Executive Directors Mr. Tang Ching Ho,GBS, JP,Chairman and Managing DirectorMs. Tang Wai ManMs. Law Man Yee, Anita Independent Non-executive Directors Mr. Siu Man Ho, Simon(Resigned on 1 November 2024)Mr. Li Ka Fai, David,MHProfessor Sit Wing Hang,GBS, JPProfessor Chan Wing Kwong,MD AUDIT COMMITTEE Mr. Li Ka Fai, David,MH,ChairmanProfessor Sit Wing Hang,GBS, JPProfessor Chan Wing Kwong,MDMr. Siu Man Ho, Simon(Resigned on 1 November 2024) REMUNERATION COMMITTEE Professor Sit Wing Hang,GBS, JP,ChairmanProfessor Chan Wing Kwong,MDMr. Li Ka Fai, David,MH(Appointed on 1 November 2024)Mr. Tang Ching Ho,GBS, JPMs. Tang Wai ManMr. Siu Man Ho, Simon,Chairman(Resigned on 1 November 2024) NOMINATION COMMITTEE Professor Chan Wing Kwong,MD,ChairmanMr. Li Ka Fai, David,MH(Appointed on 1 November 2024)Professor Sit Wing Hang,GBS, JPMr. Tang Ching Ho,GBS, JPMs. Tang Wai ManMr. Siu Man Ho, Simon(Resigned on 1 November 2024) EXECUTIVE COMMITTEE Mr. Tang Ching Ho,GBS, JP,ChairmanMs. Tang Wai ManMs. Law Man Yee, Anita Corporate Information(Continued)公司資料 AUTHORISED REPRESENTATIVES Under Listing RulesMr. Tang Ching Ho,GBS, JPMs. Ng Yee Man Fiona COMPANY SECRETARY Ms. Ng Yee Man Fiona LEGAL ADVISERS • Reed Smith Richards Butler LLPGallantSullivan & Cromwell (Hong Kong) LLP AUDITOR Ernst & YoungCertified Public AccountantsRegistered Public Interest Entity Auditor PRINCIPAL BANKERS United Overseas Limited, Hong Kong BranchTaiwan Shin Kong Commercial Bank Co., LtdCTBC Bank Co., Ltd.DBS Bank (Hong Kong) LimitedThe Hongkong and Shanghai Banking Corporation Limited REGISTERED OFFICE Clarendon House2 Church StreetHamilton HM 11Bermuda Clarendon House2 Church StreetHamilton HM 11Bermuda HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS INHONG KONG 39313101 Suite 3101, 31/F., Skyline Tower39 Wang Kwong RoadKowloon BayKowloonHong Kong Corporate Information(Continued)公司資料 PRINCIPAL SHARE REGISTRAR AND TRANSFER OFFICE INBERMUDA Appleby Global Corporate Services (Bermuda) Limited Appleby Global Corporate Services (Bermuda)LimitedCanon’s Court, 22 Victoria StreetPO Box HM 1179, Hamilton HM EXBermuda Canon’s Court, 22 Victoria StreetPO Box HM 1179, Hamilton HM EXBermuda BRANCH SHARE REGISTRAR AND TRANSFER OFFICE INHONG KONG 慤1617 Tricor Investor Services Limited17/F., Far East Finance Centre16 Harcourt RoadHong Kong BOARD LOT 5,000 5,000 shares pr@waiyuentong.com INVESTOR RELATIONSEmail: pr@waiyuentong.com http://www.wyth.net HOMEPAGEhttp://www.wyth.net STOCK CODE 897 897 Chairman’s Statement主席報告 In constant pursuit of excellence over the past 128 years, “Wai Yuen Tong”has withstood a century with established reputation in providing Chinese andWestern pharmaceutical products and Chinese medicine out-patient clinicservices. I hereby express my heartfelt gratitude to all colleagues for theirdedication during the past challenging year in the inheritance of tradition, andcontribution to the health of people in the community. 經歷百載、口碑載道。128年來，「位元堂」不斷追尋中、西藥產品及中醫門診服務的精益求精。在此，我衷心感謝公司上下仝人，在過去充滿挑戰的一年裡，繼承傳統、堅定不移，為守護市民健康出一分力。 To all Shareholders, On behalf of the board of directors (the “Board” or the “Directors”)of Wai Yuen Tong Medicine Holdings Limited (the “Company” andtogether with its subsidiaries, the “Group”), I am pleased to present toyou the annual report for the year ended 31 March 2025 (the “Year” orthe “Year under Review”). Since its establishment in 1897, Wai YuenTong has always adhered to its core philosophy of “Preparing Medicinewith Dedication, Growing Strong with Reputation”. We are committedto passing down the profound wisdom of traditional Chinese medicine(“TCM”), making the TCM industry go global, and leading the industry insetting higher standards, to provide comprehensive and exquisite medicalproducts and services to each customer. BUSINESS REVIEW Currently, the Group owns the widely recognized Chinese pharmaceuticaland health food brand “Wai Yuen Tong” through Wai Yuen TongMedicine Company Limited (“Wai Yuen Tong” or “WYT Medicine”,together with its subsidiaries, the “Wai Yuen Tong Medicine Group”),and holds the internationally renowned Western pharmaceutical brands“Madame Pearl’s” and “Pearl’s” through Luxembourg MedicineCompany Limited (“Luxembourg Medicine”, together with its